Found: 10
Select item for more details and to access through your institution.
Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 231, doi. 10.1007/s40256-023-00573-w
- By:
- Publication type:
- Article
Updated Renal Dosage Recommendations for Rivaroxaban in Patients Experiencing or at Risk of Thromboembolic Disease.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 247, doi. 10.1007/s40256-023-00579-4
- By:
- Publication type:
- Article
Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 257, doi. 10.1007/s40256-023-00574-9
- By:
- Publication type:
- Article
Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Systematic Review and Meta-analysis of Anticoagulation Strategy.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 269, doi. 10.1007/s40256-023-00580-x
- By:
- Publication type:
- Article
Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 277, doi. 10.1007/s40256-023-00572-x
- By:
- Publication type:
- Article
A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 287, doi. 10.1007/s40256-023-00569-6
- By:
- Publication type:
- Article
Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 301, doi. 10.1007/s40256-023-00575-8
- By:
- Publication type:
- Article
Disparities in PCSK9 Initiation Among US Veterans with Peripheral Arterial Disease or Cerebrovascular Disease.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 311, doi. 10.1007/s40256-023-00576-7
- By:
- Publication type:
- Article
Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome Analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 323, doi. 10.1007/s40256-023-00578-5
- By:
- Publication type:
- Article
Clinical and Hemodynamic Responses to Imatinib in Pulmonary Veno-Occlusive Disease/Pulmonary Capillary Hemangiomatosis: A Retrospective Pilot Study of Five Cases and Review of the Literature.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 329, doi. 10.1007/s40256-023-00577-6
- By:
- Publication type:
- Article